Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;29(6):891-893.
doi: 10.1038/s41431-021-00816-x. Epub 2021 Feb 15.

The rise of point-of-care genetics: how the SARS-CoV-2 pandemic will accelerate adoption of genetic testing in the acute setting

John H McDermott  1   2 , John Burn  3   4   5 , Dian Donnai  6   7 , William G Newman  6   7
Affiliations

The rise of point-of-care genetics: how the SARS-CoV-2 pandemic will accelerate adoption of genetic testing in the acute setting

John H McDermott et al. Eur J Hum Genet. 2021 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

JB is a shareholder and vice chair of medical device company QuantuMDx Group Ltd. JHM, DD and WGN have no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Harper PS, Reynolds LA, Tansey EM. Clinical genetics in Britain origins and development. London: Wellcome Trust Centre for the History of Medicine at UCL; 2010.
    1. Shendure J, Balasubramanian S, Church GM, Gilbert W, Rogers J, Schloss JA, et al. DNA sequencing at 40: past, present and future. Nature. 2017;550:345–53. doi: 10.1038/nature24286. - DOI - PubMed
    1. Jobbagy Z, van Atta R, Murphy KM, Eshleman JR, Gocke CD. Evaluation of the Cepheid GeneXpert BCR-ABL Assay. J Mol Diagn. 2007;9:220–7. doi: 10.2353/jmoldx.2007.060112. - DOI - PMC - PubMed
    1. Pirmohamed M, Burnside G, Eriksson N, Jorgensen AL, Toh CH, Nicholson T, et al. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med. 2013;369:2294–303. doi: 10.1056/NEJMoa1311386. - DOI - PubMed
    1. Claassens DMF, Vos GJA, Bergmeijer TO, Hermanides RS, van’t Hof AWJ, van der Harst P, et al. A genotype-guided strategy for oral P2Y12 inhibitors in primary PCI. N Engl J Med. 2019;381:1621–31. doi: 10.1056/NEJMoa1907096. - DOI - PubMed

Publication types